This inventor holds 1 USPTO granted patent. Top assignee: Janssen Sciences Ireland Uc. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Xavier Marc Bourdrez: Pioneering Innovator from Louviers, France
Introduction:
Xavier Marc Bourdrez is a visionary inventor hailing from the charming town of Louviers, France. With a passion for innovation that knows no bounds, he has made remarkable contributions to the world of inventions.
Latest Patents:
Xavier Marc Bourdrez holds an impressive number of patents, with one of his most notable inventions being the "Substituted pyridine-piperazinyl analogues as RSV antiviral compounds." This groundbreaking invention revolves around novel compounds with antiviral properties, specifically targeting the replication of the respiratory syncytial virus (RSV).
Career Highlights:
Currently working at Janssen Sciences Ireland Uc, Xavier Marc Bourdrez has established himself as a prominent figure in the field of inventing. His dedication to pushing the boundaries of what is possible has led to significant advancements in antiviral research and treatment.
Collaborations:
Xavier Marc Bourdrez collaborates closely with esteemed coworkers Jerôme Emile Georges Guillemont and David Francis Alain Lançois. Together, they form a dynamic team that strives towards innovative solutions in the realm of healthcare and antiviral treatments.
Conclusion:
In conclusion, Xavier Marc Bourdrez's ingenuity and forward-thinking approach make him a true asset to the world of inventions. His relentless dedication to innovation continues to shape the landscape of antiviral research, leaving a lasting impact on the field. Louviers, France, is proud to call him one of their own.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile